Association of stage shift and population mortality among patients with non–small cell lung cancer
23 December 2021
There is a stage shift for non-small cell lung cancer that could substantially confound the evaluation of newer therapeutics and mortality outcomes. This study found that the stage shift from later to earlier stage disease over the last decade was associated with improved mortality among people with lung cancer.
This article was originally published in JAMA Network Open.
Explore more tags from this article
About the Author(s)
Raja Flores
Parth Patel
Naomi Alpert
Emanuela Taioli
Contact us
We’re here to help you break through complex challenges and achieve next-level success.
Association of stage shift and population mortality among patients with non–small cell lung cancer
The stage shift from later to earlier stage disease over the last decade was associated with improved mortality among people with lung cancer.
Raja Flores, Parth Patel, Naomi Alpert, Bruce Pyenson, Emanuela Taioli